chr1-196747245-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PS1_ModeratePM1PM2PP3_ModeratePP5
The NM_000186.4(CFH):c.3628C>T(p.Arg1210Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000137 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt.
Frequency
Consequence
NM_000186.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFH | NM_000186.4 | c.3628C>T | p.Arg1210Cys | missense_variant | 22/22 | ENST00000367429.9 | NP_000177.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFH | ENST00000367429.9 | c.3628C>T | p.Arg1210Cys | missense_variant | 22/22 | 1 | NM_000186.4 | ENSP00000356399.4 | ||
ENSG00000289697 | ENST00000696032.1 | c.3580+48C>T | intron_variant | ENSP00000512341.1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251244Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135776
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461694Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 99AN XY: 727160
GnomAD4 genome AF: 0.000177 AC: 27AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74346
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 18, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 20, 2024 | PS3, PS4 - |
Age related macular degeneration 4 Pathogenic:1Other:1
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 09, 2018 | Across a selection of the available literature, the CFH c.3628C>T (p.Arg1210Cys) missense variant has been identified in a heterozygous state in at least 70 patients with macular degeneration (Raychaundhuri et al. 2011; Zhan et al. 2013; Seddon et al. 2014; Duvvari et al. 2015). The p.Arg1210Cys variant was reported in a heterozygous state in two out of over 4,480 controls and is reported at a frequency of 0.00031 in the European (non-Finnish) population of the Genome Aggregation Database. Functional analysis of the p.Arg1210Cys variant using serum from a heterozygous individual as well as recombinant factor H protein suggests this variant reduces the binding of factor H to various ligands including heparin, endothelial cells, and Cb3 (Manuelian et al. 2003). Based on the collective evidence, the p.Arg1210Cys variant is classified as pathogenic for macular degeneration. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Hemolytic uremic syndrome, atypical, susceptibility to, 1 Other:2
risk factor, no assertion criteria provided | literature only | OMIM | Jul 01, 2015 | - - |
not provided, no classification provided | literature only | GeneReviews | - | Common pathogenic variant [Martinez-Barricarte et al 2008] - |
Factor H deficiency;C0730295:Basal laminar drusen;C1853147:Age related macular degeneration 4;C2749604:Hemolytic uremic syndrome, atypical, susceptibility to, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 30, 2021 | - - |
Factor H deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2015 | - - |
Atypical hemolytic-uremic syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Sydney Genome Diagnostics, Children's Hospital Westmead | Oct 25, 2018 | This patient is homozygous for a known pathogenic variant, c.3628C>T p.(Arg1210Cys), in the CFH gene. This variant, located in the C-terminal of complement factor H (CFH), has been shown in functional assays to reduce the binding of the central complement component C3b/C3d to heparin and endothelial cells (Manuelian et al 2003 J. Clin. Invest. 111:1181-90). Testing of the parental samples revealed both the father (see MG-15-2426) and mother (see MG-15-2425) are heterozygous for the c.3628C>T p.(Arg1210Cys) variant and confirms homozygosity for this variant in this patient. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2023 | - - |
Kidney disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jan 16, 2017 | - - |
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 16, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Basal laminar drusen Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 16, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at